[Tissue diminution of vasoactive polypeptide in Hirschsprung's disease].
作者信息
Dupont C, Besson J, Laburthe M, Bataille E, Rosselin G, Navarro J
出版信息
Nouv Presse Med. 1977 Nov 26;6(40):3752.
PMID:604933
Abstract
摘要
相似文献
1
[Tissue diminution of vasoactive polypeptide in Hirschsprung's disease].[先天性巨结肠症中血管活性多肽的组织减少]
Nouv Presse Med. 1977 Nov 26;6(40):3752.
2
Reduced tissue content of vasoactive intestinal peptide in aganglionic colon of Hirschsprung's disease.
Am J Surg. 1981 Feb;141(2):243-4. doi: 10.1016/0002-9610(81)90167-7.
3
Receptors for vasoactive intestinal polypeptide on crude smooth muscle membranes from porcine uterus.
Endocrinology. 1982 Jun;110(6):2037-43. doi: 10.1210/endo-110-6-2037.
4
[New information about VIP (vasoactive intestinal peptide) in the female genital tract].[女性生殖道中血管活性肠肽（VIP）的新信息]
Cesk Gynekol. 1981 Apr;46(3):199-201.
5
[Chronic diarrhea, ganglioneuroma and vasoactive intestinal polypeptide (VIP)].[慢性腹泻、神经节瘤与血管活性肠肽（VIP）]
Monatsschr Kinderheilkd (1902). 1977 May;125(5):462-3.
6
Lack of hepatic inactivation of canine vasoactive intestinal peptide.犬血管活性肠肽缺乏肝脏失活作用。
Gastroenterology. 1977 Oct;73(4 Pt 1):768-71.
7
Vasoactive intestinal peptide (VIP): tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay.血管活性肠肽（VIP）：通过放射免疫测定法和放射受体测定法测定其在大鼠体内的组织分布。
Acta Endocrinol (Copenh). 1978 Apr;87(4):799-810. doi: 10.1530/acta.0.0870799.
8
[The VIP peptidergic system. Role in pathology and therapeutics (author's transl)].
Rev Med Brux. 1981 Apr;2(4):353-5.
9
Degradation of vasoactive intestinal polypeptide by tissue homogenates.组织匀浆对血管活性肠肽的降解作用。
Biochem Biophys Res Commun. 1980 Jan 29;92(2):669-74. doi: 10.1016/0006-291x(80)90385-x.
Zotero 插件